Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Cash from Operations (2016 - 2025)

Iradimed (IRMD) has disclosed Cash from Operations for 13 consecutive years, with 5922572.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 1.07% to 5922572.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 24947000.0 through Dec 2025, down 2.64% year-over-year, with the annual reading at 24947000.0 for FY2025, 2.64% down from the prior year.
  • Cash from Operations for Q4 2025 was 5922572.0 at Iradimed, down from 6986075.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9115714.0 in Q3 2024, with the low at 943081.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 4266843.95, with a median of 3897817.0 recorded in 2023.
  • The sharpest move saw Cash from Operations tumbled 64.64% in 2023, then soared 554.54% in 2024.
  • Over 5 years, Cash from Operations stood at 3366043.0 in 2021, then fell by 9.72% to 3038844.0 in 2022, then increased by 28.75% to 3912480.0 in 2023, then surged by 53.01% to 5986606.0 in 2024, then dropped by 1.07% to 5922572.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 5922572.0, 6986075.0, and 7746261.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.